The RNA inhibitor olpasiran significantly reduces a type of "bad cholesterol" that's associated with a high risk of ...

Despite their potential, RNA-based therapies are faced with major challenges: The instability of RNA and its rapid degradation in the body, combined with the necessity of ultra-cold storage or ...

The Penn Center for Innovation has enabled world-changing advancements, from mRNA vaccines to CAR T cancer treatments.

To present the pioneering concept, Peer and his team encoded the anti-inflammatory protein interleukin-10 into mRNA and ...

Left to right - Dr. Riccardo Rampado & Prof. Dan Peer. Researchers at Tel Aviv University have achieved a breakthrough in ...

A research team led by Professor Won Jong Kim from the Department of Chemistry at POSTECH, in collaboration with the Korea ...

A research team from POSTECH has developed a biodegradable polymer-based delivery system that efficiently transports mRNA.

The LNP-mRNA modality is a novel approach that uses lipid nanoparticles to deliver messenger RNA into cells. The mRNA acts as ...

POSTECH Professor Won Jong Kim’s Team Develops a Next-Generation mRNA Vaccine Delivery System Using Biodegradable Polymers.

The global Oligonucleotide CDMO Market, valued at US$2.33 billion in 2023, is forecasted to grow at a robust CAGR of 21.8%, ...

Scientists have progressed from merely provoking an anti-cancer immune response to designing it ...